ENTITY
Scilex

Scilex (SCLX US)

12
Analysis
Health Care • United States
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido® for postherpetic neuralgia, ELYXYB® for migraine, and GLOPERBA® for gout flares. The company is headquartered in Palo Alto, California, and was founded in 2019.
more
Exchange Announcement • 30 Sep 2026 04:07

Current Report (Form 8-K | Period ending 2026-09-25)

Exchange Announcement • 15 Aug 2026 04:41

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 13 Aug 2026 05:18

Current Report (Form 8-K | Period ending 2026-08-08)

Exchange Announcement • 23 Jul 2026 05:30

Current Report (Form 8-K | Period ending 2026-07-18)

Exchange Announcement • 06 Jul 2026 18:15

Current Report (Form 8-K | Period ending 2026-07-03)

x